Published in Medical Letter on the CDC and FDA, October 23rd, 2005
Study 1: Investigators compare intranasal and subcutaneous routes of immunization for development of a mucosal vaccine against experimental tuberculosis.
According to a study from India, "Activation of mucosal immunity in the respiratory tract is crucial for protection against respiratory infectious. Whether the intranasal route of vaccination imparts better protection against pulmonary tuberculosis than that of subcutaneous vaccination remains a debatable issue. In this study, we have investigated the effect of the routes of immunization on the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.